Found: 72
Select item for more details and to access through your institution.
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 6, p. 2489, doi. 10.1093/brain/awac480
- By:
- Publication type:
- Article
Connexins in neuromyelitis optica: a link between astrocytopathy and demyelination.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MRI to detect and localize the area postrema in multiple sclerosis: The role of 3D‐DIR and 3D‐FLAIR.
- Published in:
- Journal of Neuroimaging, 2021, v. 31, n. 4, p. 701, doi. 10.1111/jon.12867
- By:
- Publication type:
- Article
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2023.1303874
- By:
- Publication type:
- Article
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 270, doi. 10.1177/13524585221134214
- By:
- Publication type:
- Article
Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 37, doi. 10.1177/13524585221130934
- By:
- Publication type:
- Article
It is imperative to reconsider the concept of seronegative NMOSD.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1654, doi. 10.1177/13524585221111057
- By:
- Publication type:
- Article
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2052, doi. 10.1177/1352458521988926
- By:
- Publication type:
- Article
Clinical significance of a single cerebrospinal fluid immunoglobulin band: A retrospective study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1451, doi. 10.1177/1352458520978222
- By:
- Publication type:
- Article
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1458, doi. 10.1177/1352458520978218
- By:
- Publication type:
- Article
Visual field loss and structure–function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 855, doi. 10.1177/1352458520937281
- By:
- Publication type:
- Article
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS: Response to the editor.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Myelin oligodendrocyte glycoprotein antibody-associated diffuse orbital inflammation.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 11, p. 1441, doi. 10.1177/1352458519895444
- By:
- Publication type:
- Article
MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity – No.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 3, p. 274, doi. 10.1177/1352458519863135
- By:
- Publication type:
- Article
Spontaneous multiple cervical artery dissections after alemtuzumab.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 3, p. 381, doi. 10.1177/1352458519828663
- By:
- Publication type:
- Article
Area postrema syndrome: Another feature of anti-GFAP encephalomyelitis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 2, p. 253, doi. 10.1177/1352458518817992
- By:
- Publication type:
- Article
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 591, doi. 10.1177/1352458518763080
- By:
- Publication type:
- Article
Unusual presentations of MOG antibody-associated central nervous system demyelination: Expanding the spectrum.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1377, doi. 10.1177/1352458516678474
- By:
- Publication type:
- Article
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1231, doi. 10.1177/1352458516630823
- By:
- Publication type:
- Article
Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 3, p. 312, doi. 10.1177/1352458515591071
- By:
- Publication type:
- Article
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 7, p. 953, doi. 10.1177/1352458514554056
- By:
- Publication type:
- Article
Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.721877
- By:
- Publication type:
- Article
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079083
- By:
- Publication type:
- Article
The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02686
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 1, p. 94, doi. 10.1001/jamaneurol.2019.2670
- By:
- Publication type:
- Article
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 4, p. 478, doi. 10.1001/jamaneurol.2017.4601
- By:
- Publication type:
- Article
Minor Salivary Gland Biopsy for the Diagnosis of Neurosarcoidosis.
- Published in:
- European Neurology, 2023, v. 86, n. 3, p. 171, doi. 10.1159/000529920
- By:
- Publication type:
- Article
Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
- Published in:
- PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0238301
- By:
- Publication type:
- Article
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
- Published in:
- Brain: A Journal of Neurology, 2010, v. 133, n. 9, p. 2578, doi. 10.1093/brain/awq177
- By:
- Publication type:
- Article
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multiple sclerosis broke my heart.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody-associated acute demyelinating syndromes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Myelin oligodendrocyte glycoprotein antibodies associated disease: how important are B cells?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5545, doi. 10.1007/s00415-023-11908-7
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 1, p. 32, doi. 10.1007/s00415-022-11353-y
- By:
- Publication type:
- Article
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 7, p. 1743, doi. 10.1007/s00415-019-09328-7
- By:
- Publication type:
- Article
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 9, p. 1985, doi. 10.1007/s00415-018-8956-y
- By:
- Publication type:
- Article
MOG antibody-related disorders: common features and uncommon presentations.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 9, p. 1945, doi. 10.1007/s00415-017-8583-z
- By:
- Publication type:
- Article
Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 5, p. 981, doi. 10.1007/s00415-016-8092-5
- By:
- Publication type:
- Article
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 1, p. 140, doi. 10.1007/s00415-015-7952-8
- By:
- Publication type:
- Article
Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 10, p. 2329, doi. 10.1007/s00415-015-7852-y
- By:
- Publication type:
- Article
Ependyma: a new target for autoantibodies in neuromyelitis optica?
- Published in:
- Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac307
- By:
- Publication type:
- Article
CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83591-5
- By:
- Publication type:
- Article
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00501
- By:
- Publication type:
- Article